Oxford-based AI drug discovery firm Exscientia is preparing to begin Phase I clinical trials with the world’s first AI-designed molecule…
29 Apr 2021
ACC selects HealthReveal’s clinical AI solution for studies
The American College of Cardiology (ACC) has selected HealthReveal’s personalised clinical AI solution for its TRANSFORM studies. The study data will be utilised for recommending life-saving patient care interventions to…
19 Apr 2021
Oregon Oncology to integrate Deep Lens’ clinical trial platform
Oregon Oncology Specialists has signed a strategic collaboration to integrate a Deep Lens’ artificial-intelligence (AI)-based clinical trial screening platform to expand patient access to clinical trials. Under the partnership, Oregon…
09 Apr 2021
Exscientia to start world-first trials of AI-designed immuno-oncology drug
Oxford-based AI drug discovery firm Exscientia is preparing to begin Phase I clinical trials with the world’s first AI-designed molecule for immuno-oncology. A joint venture between Exscientia and Evotec has…
16 Mar 2021
AiCure and IMA partner for clinical trial recruitment optimisation
US-based data analytics company AiCure and The IMA Group have formed a partnership to optimise clinical trial recruitment and patient engagement. This year-long collaboration aims to understand patient behaviour and…
11 Mar 2021
Brainlab acquires image reading software provider Mint Medical
Digital medical technology company Brainlab has acquired Mint Medical, a developer of image reading and reporting software for clinical routine and research, for an undisclosed amount. With this deal, Brainlab…
09 Mar 2021
PathAI and Labcorp partner for algorithms in oncology trials
PathAI and Labcorp have expanded their strategic collaboration, which will enable the deployment of the former’s algorithms in prospective clinical trials of cancer and other diseases. Developed using Good Clinical…
© Copyright Verdict Media Limited 2021
Powered by
